{
    "2018-08-21": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?",
                "features": {
                    "keywords": [
                        "Franklin",
                        "LibertyQ",
                        "U.S.",
                        "Equity",
                        "ETF",
                        "FLQL",
                        "Investing"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-17",
                "original_text": "Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion",
                "features": {
                    "keywords": [
                        "Merck",
                        "FDA",
                        "Keytruda",
                        "Lung",
                        "Cancer",
                        "Label",
                        "Expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-20",
                "original_text": "A Look at Teva Pharmaceuticalâ€™s Valuation Multiples in August",
                "features": {
                    "keywords": [
                        "Teva",
                        "Pharmaceutical",
                        "Valuation",
                        "Multiples",
                        "August"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2017-11-05",
                "original_text": "Recent Developments at Allergan",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Developments"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}